LOINC
Version 2.68

95125-1SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by ImmunoassayActive

Term Description

Qualitative detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. The assay does not distinguish between IgA and IgM.
Source: Regenstrief LOINC

Fully-Specified Name

Component
SARS coronavirus 2 Ab.IgA+IgM
Property
PrThr
Time
Pt
System
Ser/Plas
Scale
Ord
Method
IA

Additional Names

Short Name
SARS-CoV-2 IgA+IgM SerPl Ql IA
Display Name
SARS-CoV-2 (COVID-19) IgA+IgM IA Ql

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.68
Last Updated
Version 2.68
Order vs. Observation
Both

Example Answer List LL2009-0

Source: ARUP Laboratories

Answer Code Score Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value) LA11885-3

Reference Information

Type Source Reference
Webcontent Lab Tests Online®Copyright Copyright © 2001-2019 American Association for Clinical Chemistry Coronavirus (COVID-19) Testing

Member of these Groups

LG51018-6 SARSCoV2 antibody detection

Language Variants Get Info

zh-CNChinese (CHINA)
SARS 冠状病毒 2 抗体.IgA+IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法
de-DEGerman (GERMANY)
SARS Coronavirus 2 Ak.IgA+IgM:NW:Pkt:Ser/Plas:Ord:IA

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95125-1